Scenarios that move HCM

HUTCHMED (China) Limited - American Depositary Shares

Scenarios that move HCM: 1 analysis, 1 positive, 0 negative.

  1. · Novo and Hengrui sign exclusive license for oral GLP-1/GIP drug — ▲ · impact +30 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing